Expression of obesity markers and persistent organic pollutants levels in adipose tissue of obese patients: Reinforcing the obesogen hypothesis?

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pereira Fernandes, Anna ^a   Dirinck, Eveline ^b   Dirtu, Alin C ^a   Malarvannan, Govindan ^a   Covaci, Adrian ^a   Van Gaal, Luc ^b   Vanparys, Caroline ^a   Jorens, Philippe G ^b   Blust, Ronny ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ENVIRONMENTAL CHEMICAL; LEPTIN; OBESOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYCHLORINATED BIPHENYL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPONECTIN GENE; ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BIOACCUMULATION; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; INTRAABDOMINAL FAT; LEPTIN GENE; MALE; MARKER GENE; OBESITY; OBESOGEN HYPOTHESIS; PATHOGENESIS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PERSISTENT ORGANIC POLLUTANT; POLLUTANT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEX DIFFERENCE; SUBCUTANEOUS TISSUE; TISSUE LEVEL; TUMOR NECROSIS FACTOR ALPHA GENE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; SUBCUTANEOUS FAT; YOUNG ADULT;

EID: 84897560341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084816     Document Type: Article

References (44)

1. La Merrill M, Emond C, Kim MJ, Antignac JP, Le Bizec B, et al. (2013) Toxicological function of adipose tissue: focus on persistent organic pollutants. Environ Health Perspect 121: 162-169.
2. Mullerova D, Kopecky J (2007) White adipose tissue: storage and effector site for environmental pollutants. Physiol Res 56: 375-381.
3. Grun F, Blumberg B (2006) Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147: S50-55. (Pubitemid 43764590)
4. Tang-Peronard JL, Andersen HR, Jensen TK, Heitmann BL (2011) Endocrinedisrupting chemicals and obesity development in humans: a review. Obes Rev 12: 622-636.
5. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA (2008) Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 116: 761-768. (Pubitemid 351943932)
6. Taxvig C, Dreisig K, Boberg J, Nellemann C, Schelde AB, et al. (2012) Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARgamma activation. Mol Cell Endocrinol 361: 106-115.
7. Hoppe AA, Carey GB (2007) Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring) 15: 2942-2950. (Pubitemid 351256655)
8. Baker NA, Karounos M, English V, Fang J, Wei Y, et al. (2013) Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice. Environ Health Perspect 121: 105-110.
9. Lyche JL, Nourizadeh-Lillabadi R, Almaas C, et al. (2010) Natural mixtures of persistent organic pollutants (POP) increase weight gain, advance puberty, and induce changes in gene expression associated with steroid hormones and obesity in female zebrafish. Journal of toxicology and environmental health. Part A 73:1032-57.
10. Pereira-Fernandes A, Vanparys C, Hectors TL, Vergauwen L, Knapen D, et al. (2013) Unraveling the mode of action of an obesogen: Mechanistic analysis of the model obesogen tributyltin in the 3T3-L1 cell line. Mol Cell Endocrinol 370: 52-64.
11. Janesick A, Blumberg B (2011) Minireview: PPAR gamma as the target of obesogens. Journal of Steroid Biochemistry and Molecular Biology 127: 4-8.
12. Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19: 525-546.
13. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 1827-1832. (Pubitemid 30421764)
14. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33. (Pubitemid 38082408)
15. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614. (Pubitemid 27446179)
16. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 11: 85-97.
17. Malarvannan G, Dirinck E, Dirtu AC, Pereira-Fernandes A, Neels H, et al. (2013) Distribution of persistent organic pollutants in two different fat compartments from obese individuals. Environ Int 55: 33-42.
18. van der Kooy K, Seidell JC (1993) Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 17: 187-196.
19. Elobeid MA, Padilla MA, Brock DW, Ruden DM, Allison DB (2010) Endocrine Disruptors and Obesity: An Examination of Selected Persistent Organic Pollutants in the NHANES 1999-2002 Data. International Journal of Environmental Research and Public Health 7: 2988-3005.
20. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR (2007) Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50: 1841-1851. (Pubitemid 47222867)
21. Lee DH, Jacobs DR (2006) A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: Results from the National Health and Nutrition Examination Survey 1999-2002 - Response to Porta. Diabetes Care 29: 2568-2568.
22. Wajchenberg BL, Giannella-Neto D, da Silva MER, Santos RF (2002) Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Hormone and Metabolic Research 34: 616-621. (Pubitemid 36398695)
23. Samaras K, Botelho NK, Chisholm DJ, Lord RV (2010) Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring) 18: 884-889.
24. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, et al. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47: 1384-1391. (Pubitemid 28396940)
25. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, et al. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47: 98-103. (Pubitemid 28030814)
26. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, et al. (2004) Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219: 9-15. (Pubitemid 38638516)
27. Dusserre E, Moulin P, Vidal H (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500: 88-96. (Pubitemid 29525402)
28. Giusti V, Verdumo C, Suter M, Gaillard RC, Burckhardt P, et al. (2003) Expression of peroxisome proliferator-activated receptor-gamma(1) and peroxisome proliferator-activated receptor-gamma(2) in visceral and subcutaneous adipose tissue of obese women. Diabetes 52: 1673-1676. (Pubitemid 36792455)
29. Garaulet M, Perez-Llamas F, Fuente T, Zamora S, Tebar FJ (2000) Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor factor-alpha, sex hormonebinding globulin and sex hormones. European Journal of Endocrinology 143: 657-666.
30. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770. (Pubitemid 28485436)
31. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, et al. (2003) Association between adiponectin and mediators of inflammation in obese women. Diabetes 52: 942-947. (Pubitemid 36384264)
32. Teijeira-Fernandez E, Eiras S, Shamagian LG, Somoza AS, Delgado C, et al. (2011) Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome. Cytokine 54: 185-190.
33. Perrini S, Laviola L, Cignarelli A, Melchiorre M, De Stefano F, et al. (2008) Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 51: 155-164. (Pubitemid 350197987)
34. Geer EB, Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6 Suppl 1: 60-75.
35. Karastergiou K, Smith SR, Greenberg AS, Fried SK (2012) Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ 3: 13.
36. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G (2003) Adiponectin expression from human adipose tissue - Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779-1785. (Pubitemid 36792470)
37. Henry RR (1997) Thiazolidinediones. Endocrinology and Metabolism Clinics of North America 26: 553-&.
38. Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, et al. (2006) Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity 14: 1543-1552. (Pubitemid 46214821)
39. Kouidhi S, Jarboui S, Marrakchi R, Froidevaux MSC, Seugnet I, et al. (2011) Adiponectin expression and metabolic markers in obesity and Type 2 diabetes. Journal of Endocrinological Investigation 34: E16-E23.
40. Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, et al. (2011) Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect 119: 377-383.
41. Mullerova D, Kopecky J, Matejkova D, Muller L, Rosmus J, et al. (2008) Negative association between plasma levels of adiponectin and polychlorinated biphenyl 153 in obese women under non-energy-restrictive regime. International Journal of Obesity 32: 1875-1878.
42. Branchi I, Alleva E, Costa LG (2002) Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. Neurotoxicology 23:375-384.
43. Lilienthal H, Hack A, Roth-Harer A, Grande SW, Talsness CE (2006) Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ Health Perspect 114:194-201. (Pubitemid 43193639)
44. Suvorov A, Battista MC, Takser L (2009) Perinatal exposure to low-dose 2,29,4,49-tetrabromodiphenyl ether affects growth in rat offspring: what is the role of IGF-1? Toxicology 260:126-131.